verapamil hydrochloride
- Product NDC
- 53002-1467
- 11-digit product format
- 530021467
- Labeler code
- 53002
- Product ID
- 53002-1467_44a777e4-c946-4c92-81cb-e24960ac59d3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA090700
- Marketing category
- ANDA
- Marketing start
- 2011-08-05
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 120 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V3888OEY5R | VERAPAMIL HYDROCHLORIDE | 152-11-4 | VERAPAMIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-1467-0 | 53002146700 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (53002-1467-0) | 2019-01-01 | 0000-00-00 | No | No | Current |
| 53002-1467-3 | 53002146703 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (53002-1467-3) | 2019-01-01 | 0000-00-00 | No | No | Current |